CERS
HealthcareCerus Corporation
$1.69-0.01 (-0.59%)
Prev Close
$1.70
Open
$1.67
High
$1.74
Low
$1.63
Volume
4.34M
Market Cap
$374.6M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Cerus Corporation (CERS) has been dominated by selling, with 1 insider purchase totaling $31.3K and 6 insider sales totaling $801.1K. The most recent insider transaction was by Benjamin Richard J (officer: Chief Medical Officer), who sold $250.9K worth of shares on Mar 9, 2026. Cerus Corporation operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $374.6M.
Buys (12M)
1
$31.3K
Sells (12M)
6
$801.1K
Net Activity
Net Seller
$769.9K
Active Insiders
6
last 12 mo
CERS Price Chart
CERS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026↗ | Benjamin Richard J | officer: Chief Medical Officer | Sell | 125,894 | $1.99 | $250.9K | 943,762 |
| Mar 9, 2026↗ | Green Kevin Dennis | officer: Chief Financial Officer | Sell | 83,021 | $2.04 | $169.6K | 1,195,890 |
| Mar 9, 2026↗ | Greenman William Mariner | director, officer: President and CEO | Sell | 78,187 | $2.01 | $156.8K | 5,446,250 |
| Mar 9, 2026↗ | Jayaraman Vivek K | officer: Chief Operating Officer | Sell | 34,094 | $2.01 | $68.4K | 1,912,870 |
| Mar 9, 2026↗ | Jensen Chrystal | officer: Chief Legal Officer | Sell | 30,845 | $2.01 | $61.9K | 1,059,140 |
| Nov 24, 2025↗ | Jensen Chrystal | Chief Legal Officer | Sell | 55,000 | $1.70 | $93.5K | 0 |
| Aug 25, 2025↗ | Gregory Dean A. | Director | Buy | 25,000 | $1.25 | $31.3K | 0 |
| Mar 13, 2025↗ | Benjamin Richard J | Chief Medical Officer | Sell | 49,024 | $1.45 | $71.1K | 0 |
| Mar 13, 2025↗ | Green Kevin Dennis | Chief Financial Officer | Sell | 59,887 | $1.45 | $86.8K | 0 |
| Mar 13, 2025↗ | Greenman William Mariner | President and CEO | Sell | 193,913 | $1.45 | $281.2K | 0 |
| Mar 13, 2025↗ | Jayaraman Vivek K | Chief Operating Officer | Sell | 75,989 | $1.45 | $110.2K | 0 |
| Mar 13, 2025↗ | Jensen Chrystal | Chief Legal Officer | Sell | 49,024 | $1.45 | $71.1K | 0 |
| Mar 6, 2025↗ | Benjamin Richard J | Chief Medical Officer | Sell | 26,139 | $1.50 | $39.2K | 0 |
| Mar 6, 2025↗ | Green Kevin Dennis | Chief Financial Officer | Sell | 31,148 | $1.50 | $46.7K | 0 |
| Mar 6, 2025↗ | Greenman William Mariner | President and CEO | Sell | 60,984 | $1.50 | $91.4K | 0 |
| Mar 6, 2025↗ | Jayaraman Vivek K | Chief Operating Officer | Sell | 33,999 | $1.50 | $50.9K | 0 |
| Mar 6, 2025↗ | Jensen Chrystal | Chief Legal Officer | Sell | 27,457 | $1.50 | $41.1K | 0 |
| Mar 3, 2025↗ | Benjamin Richard J | Chief Medical Officer | Sell | 57,546 | $1.57 | $90.6K | 0 |
| Mar 3, 2025↗ | Green Kevin Dennis | Chief Financial Officer | Sell | 69,042 | $1.57 | $108.7K | 0 |
| Mar 3, 2025↗ | Greenman William Mariner | President and CEO | Sell | 23,023 | $1.55 | $35.7K | 0 |
| Mar 3, 2025↗ | Jayaraman Vivek K | Chief Operating Officer | Sell | 10,780 | $1.55 | $16.7K | 0 |
| Mar 3, 2025↗ | Jensen Chrystal | Chief Legal Officer | Sell | 66,292 | $1.58 | $104.9K | 0 |
| Dec 16, 2024↗ | Jensen Chrystal | Chief Legal Officer | Sell | 16,667 | $1.71 | $28.5K | 0 |
| Dec 13, 2024↗ | Gregory Dean A. | Director | Buy | 1,725 | $1.70 | $2.9K | 0 |
| Dec 12, 2024↗ | BJERKHOLT ERIC | Director | Sell | 20,000 | $1.79 | $35.7K | 0 |
| Sep 3, 2024↗ | Green Kevin Dennis | Chief Financial Officer | Sell | 82,657 | $2.16 | $178.7K | 0 |
| Aug 15, 2024↗ | Jensen Chrystal | Chief Legal Officer | Sell | 16,667 | $2.07 | $34.4K | 0 |
| Aug 2, 2024↗ | Benjamin Richard J | Chief Medical Officer | Sell | 21,605 | $2.50 | $54.0K | 0 |
| May 13, 2024↗ | Shan Hua | Director | Buy | 2,500 | $1.99 | $5.0K | 0 |
| May 10, 2024↗ | NACHTSHEIM JAMI K | Director | Buy | 2,000 | $1.79 | $3.6K | 0 |
| May 9, 2024↗ | Swisher Daniel N JR | Director | Buy | 2,500 | $1.88 | $4.7K | 0 |
| May 9, 2024↗ | Witney Frank | Director | Buy | 20,000 | $1.89 | $37.8K | 0 |
| Mar 12, 2024↗ | Benjamin Richard J | Chief Medical Officer | Sell | 35,115 | $2.02 | $70.8K | 0 |
| Mar 12, 2024↗ | CORASH LAURENCE M | Chief Scientific Officer | Sell | 28,427 | $2.02 | $57.3K | 0 |
| Mar 12, 2024↗ | Green Kevin Dennis | Chief Financial Officer | Sell | 42,555 | $1.99 | $84.9K | 0 |
| Mar 12, 2024↗ | Greenman William Mariner | President and CEO | Sell | 125,926 | $2.04 | $256.4K | 0 |
| Mar 12, 2024↗ | Jayaraman Vivek K | Chief Operating Officer | Sell | 53,041 | $2.02 | $106.9K | 0 |
| Mar 12, 2024↗ | Jensen Chrystal | Chief Legal Officer | Sell | 35,284 | $2.02 | $71.1K | 0 |
| Mar 12, 2024↗ | Moore Carol | SVP Reg. & Quality | Sell | 20,619 | $2.02 | $41.6K | 0 |
| Mar 8, 2024↗ | Benjamin Richard J | Chief Medical Officer | Sell | 29,378 | $2.40 | $70.5K | 0 |
| Dec 13, 2023↗ | BJERKHOLT ERIC | Director | Buy | 10,000 | $1.62 | $16.2K | 0 |
| Aug 22, 2023↗ | Lucena Ann | Director | Buy | 7,500 | $1.69 | $12.6K | 0 |
| Aug 21, 2023↗ | BJERKHOLT ERIC | Director | Buy | 10,000 | $1.72 | $17.2K | 0 |
| May 26, 2023↗ | Swisher Daniel N JR | Director | Buy | 5,000 | $1.91 | $9.5K | 0 |
| May 24, 2023↗ | SCHULZE GAIL | Director | Buy | 9,850 | $2.03 | $20.0K | 0 |
| May 23, 2023↗ | BJERKHOLT ERIC | Director | Buy | 5,000 | $2.00 | $10.0K | 0 |
| Mar 12, 2023↗ | Benjamin Richard J | Chief Medical Officer | Sell | 25,353 | $2.79 | $70.8K | 0 |
| Mar 12, 2023↗ | CORASH LAURENCE M | Chief Scientific Officer | Sell | 15,342 | $2.80 | $43.0K | 0 |
| Mar 12, 2023↗ | Green Kevin Dennis | Chief Financial Officer | Sell | 17,163 | $2.80 | $48.1K | 0 |
| Mar 12, 2023↗ | Greenman William Mariner | President and CEO | Sell | 60,480 | $2.80 | $169.3K | 0 |
Showing 1–50 of 80
1 / 2
CERS Insider Buying Activity
The following table shows recent insider purchases of Cerus Corporation (CERS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 25, 2025↗ | Gregory Dean A. | Director | Buy | 25,000 | $1.25 | $31.3K | 0 |
| Dec 13, 2024↗ | Gregory Dean A. | Director | Buy | 1,725 | $1.70 | $2.9K | 0 |
| May 13, 2024↗ | Shan Hua | Director | Buy | 2,500 | $1.99 | $5.0K | 0 |
| May 10, 2024↗ | NACHTSHEIM JAMI K | Director | Buy | 2,000 | $1.79 | $3.6K | 0 |
| May 9, 2024↗ | Swisher Daniel N JR | Director | Buy | 2,500 | $1.88 | $4.7K | 0 |
| May 9, 2024↗ | Witney Frank | Director | Buy | 20,000 | $1.89 | $37.8K | 0 |
| Dec 13, 2023↗ | BJERKHOLT ERIC | Director | Buy | 10,000 | $1.62 | $16.2K | 0 |
| Aug 22, 2023↗ | Lucena Ann | Director | Buy | 7,500 | $1.69 | $12.6K | 0 |
| Aug 21, 2023↗ | BJERKHOLT ERIC | Director | Buy | 10,000 | $1.72 | $17.2K | 0 |
| May 26, 2023↗ | Swisher Daniel N JR | Director | Buy | 5,000 | $1.91 | $9.5K | 0 |
| May 24, 2023↗ | SCHULZE GAIL | Director | Buy | 9,850 | $2.03 | $20.0K | 0 |
| May 23, 2023↗ | BJERKHOLT ERIC | Director | Buy | 5,000 | $2.00 | $10.0K | 0 |
CERS Insider Selling Activity
The following table shows recent insider sales of Cerus Corporation (CERS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026↗ | Benjamin Richard J | officer: Chief Medical Officer | Sell | 125,894 | $1.99 | $250.9K | 943,762 |
| Mar 9, 2026↗ | Green Kevin Dennis | officer: Chief Financial Officer | Sell | 83,021 | $2.04 | $169.6K | 1,195,890 |
| Mar 9, 2026↗ | Greenman William Mariner | director, officer: President and CEO | Sell | 78,187 | $2.01 | $156.8K | 5,446,250 |
| Mar 9, 2026↗ | Jayaraman Vivek K | officer: Chief Operating Officer | Sell | 34,094 | $2.01 | $68.4K | 1,912,870 |
| Mar 9, 2026↗ | Jensen Chrystal | officer: Chief Legal Officer | Sell | 30,845 | $2.01 | $61.9K | 1,059,140 |
| Nov 24, 2025↗ | Jensen Chrystal | Chief Legal Officer | Sell | 55,000 | $1.70 | $93.5K | 0 |
| Mar 13, 2025↗ | Benjamin Richard J | Chief Medical Officer | Sell | 49,024 | $1.45 | $71.1K | 0 |
| Mar 13, 2025↗ | Green Kevin Dennis | Chief Financial Officer | Sell | 59,887 | $1.45 | $86.8K | 0 |
| Mar 13, 2025↗ | Greenman William Mariner | President and CEO | Sell | 193,913 | $1.45 | $281.2K | 0 |
| Mar 13, 2025↗ | Jayaraman Vivek K | Chief Operating Officer | Sell | 75,989 | $1.45 | $110.2K | 0 |
| Mar 13, 2025↗ | Jensen Chrystal | Chief Legal Officer | Sell | 49,024 | $1.45 | $71.1K | 0 |
| Mar 6, 2025↗ | Benjamin Richard J | Chief Medical Officer | Sell | 26,139 | $1.50 | $39.2K | 0 |
| Mar 6, 2025↗ | Green Kevin Dennis | Chief Financial Officer | Sell | 31,148 | $1.50 | $46.7K | 0 |
| Mar 6, 2025↗ | Greenman William Mariner | President and CEO | Sell | 60,984 | $1.50 | $91.4K | 0 |
| Mar 6, 2025↗ | Jayaraman Vivek K | Chief Operating Officer | Sell | 33,999 | $1.50 | $50.9K | 0 |
| Mar 6, 2025↗ | Jensen Chrystal | Chief Legal Officer | Sell | 27,457 | $1.50 | $41.1K | 0 |
| Mar 3, 2025↗ | Benjamin Richard J | Chief Medical Officer | Sell | 57,546 | $1.57 | $90.6K | 0 |
| Mar 3, 2025↗ | Green Kevin Dennis | Chief Financial Officer | Sell | 69,042 | $1.57 | $108.7K | 0 |
| Mar 3, 2025↗ | Greenman William Mariner | President and CEO | Sell | 23,023 | $1.55 | $35.7K | 0 |
| Mar 3, 2025↗ | Jayaraman Vivek K | Chief Operating Officer | Sell | 10,780 | $1.55 | $16.7K | 0 |
| Mar 3, 2025↗ | Jensen Chrystal | Chief Legal Officer | Sell | 66,292 | $1.58 | $104.9K | 0 |
| Dec 16, 2024↗ | Jensen Chrystal | Chief Legal Officer | Sell | 16,667 | $1.71 | $28.5K | 0 |
| Dec 12, 2024↗ | BJERKHOLT ERIC | Director | Sell | 20,000 | $1.79 | $35.7K | 0 |
| Sep 3, 2024↗ | Green Kevin Dennis | Chief Financial Officer | Sell | 82,657 | $2.16 | $178.7K | 0 |
| Aug 15, 2024↗ | Jensen Chrystal | Chief Legal Officer | Sell | 16,667 | $2.07 | $34.4K | 0 |
| Aug 2, 2024↗ | Benjamin Richard J | Chief Medical Officer | Sell | 21,605 | $2.50 | $54.0K | 0 |
| Mar 12, 2024↗ | Benjamin Richard J | Chief Medical Officer | Sell | 35,115 | $2.02 | $70.8K | 0 |
| Mar 12, 2024↗ | CORASH LAURENCE M | Chief Scientific Officer | Sell | 28,427 | $2.02 | $57.3K | 0 |
| Mar 12, 2024↗ | Green Kevin Dennis | Chief Financial Officer | Sell | 42,555 | $1.99 | $84.9K | 0 |
| Mar 12, 2024↗ | Greenman William Mariner | President and CEO | Sell | 125,926 | $2.04 | $256.4K | 0 |
| Mar 12, 2024↗ | Jayaraman Vivek K | Chief Operating Officer | Sell | 53,041 | $2.02 | $106.9K | 0 |
| Mar 12, 2024↗ | Jensen Chrystal | Chief Legal Officer | Sell | 35,284 | $2.02 | $71.1K | 0 |
| Mar 12, 2024↗ | Moore Carol | SVP Reg. & Quality | Sell | 20,619 | $2.02 | $41.6K | 0 |
| Mar 8, 2024↗ | Benjamin Richard J | Chief Medical Officer | Sell | 29,378 | $2.40 | $70.5K | 0 |
| Mar 12, 2023↗ | Benjamin Richard J | Chief Medical Officer | Sell | 25,353 | $2.79 | $70.8K | 0 |
| Mar 12, 2023↗ | CORASH LAURENCE M | Chief Scientific Officer | Sell | 15,342 | $2.80 | $43.0K | 0 |
| Mar 12, 2023↗ | Green Kevin Dennis | Chief Financial Officer | Sell | 17,163 | $2.80 | $48.1K | 0 |
| Mar 12, 2023↗ | Greenman William Mariner | President and CEO | Sell | 60,480 | $2.80 | $169.3K | 0 |
CERS Insiders
Similar Stocks to CERS
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
SYK
Stryker Corporation
$336.96-0.07%
$129.05B
MDT
Medtronic plc
$87.06-0.37%
$112.19B
BSX
Boston Scientific Corporation
$68.91+0.51%
$101.72B
EW
Edwards Lifesciences Corporation
$81.76-3.37%
$49.14B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$273.67-3.21%
$47.35B
DXCM
DexCom, Inc.
$64.51-1.15%
$25.45B
ZBH
Zimmer Biomet Holdings, Inc.
$93.20+0.77%
$18.47B